<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/701D1ADE-DA47-488A-B8AD-6D02533A6119"><gtr:id>701D1ADE-DA47-488A-B8AD-6D02533A6119</gtr:id><gtr:name>Faculty of Medicine, Nursing and Health Sciences</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/9FAEB115-B448-4CE5-A56F-A6A270B4C57A"><gtr:id>9FAEB115-B448-4CE5-A56F-A6A270B4C57A</gtr:id><gtr:name>International Federation of Gynecology and Obstetrics (FIGO)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/F5914C2A-6AE8-4A26-ACA8-99C3D6D87514"><gtr:id>F5914C2A-6AE8-4A26-ACA8-99C3D6D87514</gtr:id><gtr:name>University of Melbourne</gtr:name><gtr:address><gtr:line1>University of Melbourne</gtr:line1><gtr:line2>Melbourne Research Office</gtr:line2><gtr:line3>Parkville</gtr:line3><gtr:line4>Melbourne</gtr:line4><gtr:line5>Victoria</gtr:line5><gtr:postCode>3010</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/DD698BE9-1ED7-42BF-AC5D-427A5CA5851D"><gtr:id>DD698BE9-1ED7-42BF-AC5D-427A5CA5851D</gtr:id><gtr:name>Bayer</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Edinburgh Research and Innovation</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/701D1ADE-DA47-488A-B8AD-6D02533A6119"><gtr:id>701D1ADE-DA47-488A-B8AD-6D02533A6119</gtr:id><gtr:name>Faculty of Medicine, Nursing and Health Sciences</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9FAEB115-B448-4CE5-A56F-A6A270B4C57A"><gtr:id>9FAEB115-B448-4CE5-A56F-A6A270B4C57A</gtr:id><gtr:name>International Federation of Gynecology and Obstetrics (FIGO)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F5914C2A-6AE8-4A26-ACA8-99C3D6D87514"><gtr:id>F5914C2A-6AE8-4A26-ACA8-99C3D6D87514</gtr:id><gtr:name>University of Melbourne</gtr:name><gtr:address><gtr:line1>University of Melbourne</gtr:line1><gtr:line2>Melbourne Research Office</gtr:line2><gtr:line3>Parkville</gtr:line3><gtr:line4>Melbourne</gtr:line4><gtr:line5>Victoria</gtr:line5><gtr:postCode>3010</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DD698BE9-1ED7-42BF-AC5D-427A5CA5851D"><gtr:id>DD698BE9-1ED7-42BF-AC5D-427A5CA5851D</gtr:id><gtr:name>Bayer</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/07CA7C33-3C80-4418-8B2A-A0B3A3B07DE4"><gtr:id>07CA7C33-3C80-4418-8B2A-A0B3A3B07DE4</gtr:id><gtr:firstName>Henry</gtr:firstName><gtr:surname>Jabbour</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/21EA1447-F026-4766-BCD9-34C3B90E210E"><gtr:id>21EA1447-F026-4766-BCD9-34C3B90E210E</gtr:id><gtr:firstName>Hilary</gtr:firstName><gtr:otherNames>Octavia</gtr:otherNames><gtr:surname>Critchley</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/0F243FCD-57DA-48E3-9933-8193EA373C82"><gtr:id>0F243FCD-57DA-48E3-9933-8193EA373C82</gtr:id><gtr:firstName>Nik</gtr:firstName><gtr:surname>Hirani</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0600048"><gtr:id>F2951EDE-BF1A-4A93-9BF5-AF661F3D6B99</gtr:id><gtr:title>Hypoxia inducible factor (HIF-1) and endometrial remodelling: relevance to menstrual bleeding</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0600048</gtr:grantReference><gtr:abstractText>Menstrual disorders impose a major impact on quality of life for healthy women and are one of the four most common reasons for seeking advice from a general practitioner. Heavy menstrual bleeding (menorrhagia) is one of the commonest indications for referral to a gynaecologist. Management typically involves invasive surgery. Current medical treatment options are often associated with side effects such as unscheduled breakthrough bleeding. We still do not know why some women experience problematic menstrual bleeding. Enhancement of our understanding of the mechanism of normal menstruation will provide an opportunity to identify novel targets for potential therapeutic development. Our proposal aims to examine the cascade of events that occur in cells of the womb-lining (endometrium) and triggered by withdrawal of the hormone, progesterone (P). This occurs at the end of each monthly cycle prior to a period or as a consequence of treatment with long-acting progestogen treatment, such as the levonorgestrel- intrauterine system (LNG-IUS). As a consequence of P-withdrawal, enzymes that are involved in the manufacture of substances known as prostaglandins (PGs) are increased in cells of the endometrium. In turn, other factors in these cells are also switched on. In the context of our study we wish to study the factors that switch on production of the molecule, HIF-1alpha and as a result the end products of this cascade that orchestrate blood vessel growth and repair in the endometrium; both necessary events to prepare for the next menstrual cycle. Further if these events are disturbed abnormal menstrual bleeding is a likely consequence. We therefore will seek participation from women attending with menstrual complaints and ask to examine small samples of the endometrium from these patients for molecular and cellular studies. Information about these molecular and cellular pathways will help us identify points in the pathway which could be new targets for treatment, especially if these treatments could be delivered directly to the uterus.</gtr:abstractText><gtr:technicalSummary>Menstrual disorders impose a significant impact on quality of life for women. It is essential to understand mechanisms involved in uterine bleeding if improved medical treatments are to be developed and
surgery (hysterectomy) avoided. Progesterone withdrawal is the trigger for menstruation, and is associated with increased expression and generation of potent vaso-active prostaglandins. We describe a case for the prostaglandin EP2 receptor, epidermal growth factor receptor (EGFR) and signalling pathway associated with their regulation of HIF-1alpha, as potential novel therapeutic targets (perhaps by local
administration) for menstrual bleeding disorders.
The functional role of HIF-1alpha in human endometrium is unknown; it may be critical to the regeneration phase of the menstrual cycle.
Tissue regeneration requires angiogenesis and matrix remodelling, processes clearly relevant to known HIF-1alpha target genes.
We propose to undertake a proof of concept study that will, in human endometrium, establish whether progesterone withdrawal and elevated prostaglandin synthesis and signalling initiate local events that lead to HIF-1alpha expression and downstream angiogenic gene expression (VEGF, CTGF, ET, Ang-2). This provides a coordinated mechanism for endometrial regeneration, that when dysregulated could result in heavy menstrual bleeding (menorrhagia). We aim to test these hypotheses in functional assays using human endometrial tissue explants derived from women with measured normal and heavy menstrual blood loss (MBL).
Our proposal addresses the following hypotheses:
(1) women with heavy menstrual bleeding have elevated endometrial HIF-1alpha expression compared to women with normal MBL.
(2)Endometrial tissue from women with heavy bleeding exhibits an altered vasculogenic potential compared to women with normal MBL. For this we will use a functional angiogenesis assay using endometrial tissue explants. (3) Novel agents (inhibitors of PGE2-EGFR-HIF-1 pathway) reduce angiogenesis in a functional explant assay through attenuated angiogenic gene expression and may represent new therapy for disorders of abnormal menstrual bleeding.</gtr:technicalSummary><gtr:fund><gtr:end>2010-07-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>487225</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Faculty of Medicine, Nursing and Health Sciences</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:department>Department of Obstetrics and Gynaecology</gtr:department><gtr:description>Development of animal models of menstruation</gtr:description><gtr:id>49750901-4F81-4188-B7F2-FE856FB2F7EC</gtr:id><gtr:impact>Provided opportunity for undergraduate medical student elective project Generation of preliminary data to support development of xenograft model of menstruation

Murine models of menstruation have now been established in MRC Centre for Reproductive Health in Edinburgh</gtr:impact><gtr:partnerContribution>Provided preliminary data to support xenograft model of menstruationShared intellectual exchange
Opportunity for medical student elective project to generate pilot data for future grant applications</gtr:partnerContribution><gtr:piContribution>Provided opportunity for undergraduate medical student elective project -- subsequent sharing of data generated Provided preliminary data to support development of xenograft model of menstruation</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Inflammation Research</gtr:department><gtr:description>Studies on uterine immune cells</gtr:description><gtr:id>38BA6133-37DA-4578-81F0-9F61ABEFB45A</gtr:id><gtr:impact>Novel preliminary data necessary for preparation of collaborative grant applications. Co-supervision of current PhD student.
Publications: 19196802 and PMID:23108100</gtr:impact><gtr:partnerContribution>Exchange of ideas and expertise (molecular and cellular)</gtr:partnerContribution><gtr:piContribution>Opportunity to study isolated immune cells from primary human uterine tissues</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Bayer</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Research collaboration with Bayer Pharma AG</gtr:description><gtr:id>F5DB1D4F-CB6E-4852-9D99-259E5FA2BD41</gtr:id><gtr:impact>New collaboration from Sept 2010
Life Sciences Workshop on Abnormal uterine bleeding: Berlin Nov 10-12 2010

Via human reproductive tract tisse resource - enabled sharing of endometrial RNA (human) resource for detailed gene microarray studies</gtr:impact><gtr:partnerContribution>Research grant to develop animal models of menstruation
- thereby providing opportunity for intellectual exchange with research scientists at Bayer Pharma AG and access to novel steroid agonists and antagonists plus other pharmacological agents for research studies</gtr:partnerContribution><gtr:piContribution>All studies will be conducted at University of Edinburgh</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Human Reproductive Sciences Unit</gtr:department><gtr:description>Studies on human endometrium</gtr:description><gtr:id>549E3B3B-D1FC-46DC-9E9D-604E4DD33BC5</gtr:id><gtr:impact>Successful joint research grant application to the Wellcome Trust Joint publications: 19955102; 19208787;19196802;18775884; 18032694; 19955102; 20668045; 20885978 
 IP - patent submitted but not supported beyond first year</gtr:impact><gtr:partnerContribution>Collaboration has generated opportunity for successful joint research grant application; shared supervision of PhD students;</gtr:partnerContribution><gtr:piContribution>Provision of intellectual input and exchange of ideas - expertise in endometrial biology Opportunity to study female reproductive disorders due to ready access to clinical primary tissue resource</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Melbourne</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:department>Department of Obstetrics and Gynaecology</gtr:department><gtr:description>Development of animal models of menstruation</gtr:description><gtr:id>C00252A6-0787-4571-A37B-4C651636C637</gtr:id><gtr:impact>Provided opportunity for undergraduate medical student elective project Generation of preliminary data to support development of xenograft model of menstruation

Murine models of menstruation have now been established in MRC Centre for Reproductive Health in Edinburgh</gtr:impact><gtr:partnerContribution>Provided preliminary data to support xenograft model of menstruationShared intellectual exchange
Opportunity for medical student elective project to generate pilot data for future grant applications</gtr:partnerContribution><gtr:piContribution>Provided opportunity for undergraduate medical student elective project -- subsequent sharing of data generated Provided preliminary data to support development of xenograft model of menstruation</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Human Reproductive Sciences Unit</gtr:department><gtr:description>Anti-inflammatory and pro-resolution mediators of endometrial repair</gtr:description><gtr:id>DECAE135-7B60-466F-8551-BA5ED71DEE55</gtr:id><gtr:impact>Co-investigator on research grant</gtr:impact><gtr:partnerContribution>Exchange of expertise, laboratory reagents and intellectual input to facilitate continuation of collaborative research</gtr:partnerContribution><gtr:piContribution>Exchange of expertise, laboratory reagents and intellectual input to facilitate continuation of collaborative research</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Reproductive Biology</gtr:department><gtr:description>Studies on human fallopian tube and ectopic pregnancy</gtr:description><gtr:id>DF404173-0B1B-4AAA-97E2-F3BB8883CBB1</gtr:id><gtr:impact>Mentorship of trainee clinical academic who subsequently has been awarded an MRC Clinician Scientist Fellowship 2009-13 Successful joint grant awarded from Wellbeing of Women 2008-10 Joint publications: 19864448; 20047737; 20651036; 20864676; 20978183; 21047920; PMID:22685224</gtr:impact><gtr:partnerContribution>Intellectual input and exchange of ideas. Development of collaborative research programme</gtr:partnerContribution><gtr:piContribution>Provision of intellectual input and exchange of ideas - expertise in uterine biology Opportunity to study female reproductive disorders due to ready access to clinical primary tissue resource</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>International Federation of Gynecology and Obstetrics (FIGO)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>FIGO Menstrual Disorders Working Group</gtr:description><gtr:id>7196101F-3528-4EEB-98D2-7C77501B29A0</gtr:id><gtr:impact>Publications:
PMID 22386064
PMID 22068978
PMID 22065329
PMID 22065324</gtr:impact><gtr:partnerContribution>Established a FIGO endorsed classification for abnormal uterine bleeding. Within this classification is a sub-classification &amp;quot;Endometrium&amp;quot; molecular and cellular causes of abnormal uterine bleeding and studies arising from this MRC funding have helped inform endometrial biology in this area.

Also within this classification is a sub-classification for fibroids</gtr:partnerContribution><gtr:piContribution>Current member FIGO menstrual disorders committee (previously Co-Chair with colleagues from USA and Australia).</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Inflammation Research</gtr:department><gtr:description>Studies on female reproductive tract injury and repair</gtr:description><gtr:id>F3150508-44A5-4025-A6FF-2CE3A24CFF73</gtr:id><gtr:impact>MRC British Lung Foundation Capacity Building PhD studentship</gtr:impact><gtr:partnerContribution>Exchange of ideas and expertise and continuation of a joint collaborative research programme</gtr:partnerContribution><gtr:piContribution>Exchange of ideas and expertise and continuation of a joint collaborative research programme</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Inflammation Research</gtr:department><gtr:description>Studies on human female reproductive tract tissues (endometrium, ovarian surface epithelium, fallopian tube, peritoneum)</gtr:description><gtr:id>FC79524E-A853-45FB-B64F-8B2CFB5CD89C</gtr:id><gtr:impact>Joint successful grant application to MRC [2009-2012. MRC Project Grant. &amp;pound;700870 &amp;quot;Postovulatory ovarian repair: a role for LOX in scar-free adult healing]

Through Research collaboration with Bayer Pharma - sharing of endometrial RNA resource</gtr:impact><gtr:partnerContribution>Collaborative discussions have generated opportunity for joint research grant applications and shared supervision of PhD students Opportunity to share reagents and technical laboratory expertise</gtr:partnerContribution><gtr:piContribution>Provision of intellectual input and exchange of ideas - technical (molecular &amp;amp; cellular study expertise) Opportunity to study female reproductive disorders due to access to clinical primary tissue resource</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Public Talk (2014)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>1A5F8564-A483-427E-99D0-E4A4C5AB2629</gtr:id><gtr:impact>MRC Centre for Reproductive Health Public Talk, Edinburgh 19 February 2014. Invited speaker: Blood Vessel Route to Solving Problem Periods. Audience mainly school pupils and the public.

Audience mainly school pupils and the public and event received positive feedback. Discussion with school pupils and general public about impact of research on important women's health clinical complaints. Interest expressed in work experience at Edinburgh Royal Infirmary by one member of audience who subsequently obtained one week work experience placement June 2014.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited speaker and participant Life Science Workshop (Bayer Schering Pharma Ag) 2010</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E4561026-E9D7-4126-8160-5940EAD4E402</gtr:id><gtr:impact>Scientific Meeting, Scientific Workshop on &amp;quot;Abnormal Uterine Bleeding&amp;quot;, Bayer Schering Pharma AG, Berlin 10-12 November 2010. Invited speaker: Heavy Menstrual Bleeding: evidence for disturbed &amp;quot;injury and repair&amp;quot;.

Raised profile to industry of importance of menstrual bleeding problems and impact of menstrual disorders of health and quality of life to many women
This &amp;quot;Life Sciences&amp;quot; workshop also explored potential mechanistic pathways for future therapeutic targets</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>media article on menstruation (Why Menstruation Remains a Medical Mystery: https://uk.news.yahoo.com/why-menstruation-remains-medical-mystery-215459035.html)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>079F02A0-13B9-4E27-B219-ABAD6F61C2EC</gtr:id><gtr:impact>media interest in article (peer-reviewed - review type article highlighting research contributions) on menstruation: Live Science.com
https://uk.news.yahoo.com/why-menstruation-remains-medical-mystery-215459035.html</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>https://uk.news.yahoo.com/why-menstruation-remains-medical-mystery-215459035.html</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Max Perutz Science writing prize 2009</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A9D497B7-65A9-45F5-92AB-5E3E85F26E95</gtr:id><gtr:impact>Annual MRC science writing award [Max Perutz prize] awarded to Clinical Research Fellow studying for PhD and funded from this grant

Further exposure in the media: BBC interview on Radio 4 [Leading Edge BBC radio program]. Further radio invitation from BBC Radio &amp;quot;Moments of Genius&amp;quot; to celebrate the international year of science in 2010. Its a two minute slot to discuss a moment of genius in science. Scientists and famous people have been asked to take part. They are to be used as fillers in the Today programme.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> Invited speaker and participant Scientific Workshop (Bayer Schering Pharma Ag) 2008</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C8BA678A-36D7-4919-A03C-4CDDCB49620C</gtr:id><gtr:impact>Scientific Meeting, Scientific Workshop on &amp;quot;IUS and Uterine Bleeding&amp;quot;, Bayer Schering Pharma AG, Berlin 9-10 June 2008 Invited speaker: Human endometrial function: role of progesterone withdrawal in endometrial (breakthrough) bleeding.

Raised profile to industry of importance of menstrual bleeding problems and impact of menstrual disorders of health and quality of life to many women</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Lecture (2012)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>6184CCC7-C2E0-4EE4-8027-6DD3FE04B457</gtr:id><gtr:impact>MRC Centre for Reproductive Health Public Talk, Edinburgh 25 January 2012. Invited speaker: Heavy menstrual bleeding: a period drama. Audience mainly school pupils and the public.

Audience mainly school pupils and the public and event received positive feedback. Discussion with school pupils and general public about impact of research on important women's health clinical complaints.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited speaker and participant Scientific Meeting (Preglem 2012)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D5DBAC9C-7CD2-4C42-892E-709F57496D4C</gtr:id><gtr:impact>Scientific Meeting on &amp;quot;SPRMs and a new treatment for uterine fibroids&amp;quot;, Preglem , Leeds 22 May 2012. Invited speaker: Progesterone receptor modulators (PRMs), effects on the endometrium.

Raised profile to indudstry of importance of menstrual bleeding problems and impact of menstrual disorders of health and quality of life to many women.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public lecture (2008)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>BC694BD5-2B47-477C-98BF-09B26B9E48D0</gtr:id><gtr:impact>Centre for Reproductive Biology Public lecture series, Edinburgh Invited speakers: Periods: a bleeding pain! Will it ever be possible to make every week of the month bearable? Audience mainly school students and the public

Audience mainly school students and the public and event received positive feedback Discussion with school pupils and general public about impact of research on important women's health clinical complaints</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public lecture (2010)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>C605A7A7-C1CE-4D0B-A41C-D5E44CAB397E</gtr:id><gtr:impact>Centre for Reproductive Biology Public lecture series, Edinburgh Invited speaker: A womb with a view: a closer look at endometriosis and fibroids.
Opportunity to disseminate information to a lay audience about importance of understanding basis for problematic monthly bleeding.

Audience mainly school students and the public and event received positive feedback Discussion with school pupils and general public about impact of research on important women's health clinical complaints</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited  speaker MRC Showcase Programme (Edinburgh)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>605A33E9-6220-4724-8984-E5A0946D33DE</gtr:id><gtr:impact>MRC Showcase Programme, Physiological Systems and Clinical Sciences Board, 11 - 12 September 2007. Edinburgh. Inflammation Invited speaker: Injury and repair in the female reproductive tract. Audience was mixture of scientists from academia and industry

FIGO international meeting Rome; topic abnormal uterine bleeding; Audience was mixture of scientists and clinicians from academia, industry and in clinical practice 


Co-organiser &amp;amp; speaker at industry (Bayer Schering Pharma) forum on abnormal uterine bleeding, Berlin Germany -- 20-30 international experts (academia &amp;amp; industry)

Speaker at Nordic Ob/GYN society (Norway) annual meeting (approx 100 participants)

Discussions with scientists working in industry</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007,2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio interview BBC Scotland's Newsdrive</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>BAD24F63-C9B1-444A-AB28-31D8203959CA</gtr:id><gtr:impact>Interviewed by BBC Scotland Newsdrive programme on subject of studies on helping women with heavy menstrual bleeding.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Pathways to Professions Public Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>21CA6918-0BD6-49E1-95AE-60831131F128</gtr:id><gtr:impact>Pathways to Professions Public Lecture

xx Work experience</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1642538</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Developmental Clinical Studies Grant</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/J003611/1</gtr:fundingRef><gtr:id>060149E8-142D-4674-86FB-14B538AC8DAD</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>726874</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant 0900550</gtr:description><gtr:end>2013-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>29C05F7A-D6AA-426F-83A1-F19855B74635</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>247472</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Dr J Maybin (PhD funded through MRC Grant G0600048) has gone on to be awarded a Wellcome Trust Postgraduate Training Fellowship (Clinical Academic)</gtr:description><gtr:end>2015-07-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:fundingRef>100646/Z/12/Z</gtr:fundingRef><gtr:id>341B7D5B-81FE-45CF-8D48-5A840531C5A0</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1086000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Centre application (G1002033)</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G1002033</gtr:fundingRef><gtr:id>C26DD6B3-57CE-46FC-977E-7D3335D6733E</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Use of antagonists for receptors of prostaglandin E2 (EP2 and EP4) for treatment of benign endometrial pathologies. Our collaborative studies have demonstrated receptors of prostaglandin E2 are elevated in a number of endometrial pathologies. Suppression of receptor function reduces/ inhibits these pathways with potential for therpeutic benefit.</gtr:description><gtr:id>FF276798-04BB-4413-AD57-9BE69EB9EB94</gtr:id><gtr:impact>Unknown</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:patentId>US2008206309</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>EP receptor antagonists</gtr:title><gtr:yearProtectionGranted>2008</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>FP receptors are elevated in several endometrial pathologies</gtr:description><gtr:id>4CC8A469-65FD-48CA-8755-C20404BDC347</gtr:id><gtr:impact>Unknown</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:patentId>US2007004620</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>FP receptor antagonist</gtr:title><gtr:yearProtectionGranted>2007</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Industry advisory committee (Bayer Schering Pharma AG)</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>9E1966B4-E8E4-47A4-84BE-507FB94F1077</gtr:id><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Contributed to FIGO endorsed classification of Abnormal Uterine Bleeding (AUB)</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>08C91853-8515-4535-8AA6-4FD7BCDA4C91</gtr:id><gtr:impact>Aim is to streamline classification of menstrual bleeding disorders
MRC funded Research has contributed to the molecular &amp;amp; cellular understanding of menstrual bleeding disorders - a component within this classification.

PI on MRC funded work is co-chair of this initiative

Publications relevant are: PMID:22386064;PMID:22065326;PMID:22065324; PMID:21496802;PMID:21345435</gtr:impact><gtr:type>Influenced training of practitioners or researchers</gtr:type><gtr:url>http://europepmc.org/abstract/MED/22386064</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Launch of Advice Paper on Women, Work and Care at Royal Society of Edinburgh</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DF7EF409-D7A0-4800-9BB3-1F4C77DD7AA2</gtr:id><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>Exploration of first-in-woman use of a short oral course of low-dose dexamethasone to rescue local endometrial glucocorticoid deficiency in women with heavy menstrual bleeding (HMB)</gtr:description><gtr:id>C09D66B6-407D-4F0B-BC22-BAEDC86158F0</gtr:id><gtr:impact>Study in progress</gtr:impact><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>DexFEM</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2013</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Human female reproductive tract tissue resource -- archival tissue resource (endometrium) = well-characterised/ phenotyped</gtr:description><gtr:id>3E644B5F-5C5A-453A-A1BA-D2A48C85065A</gtr:id><gtr:impact>valuable human female reproductive tract tissue resource -- archival tissue resource (endometrium) = well-characterised/ phenotyped</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Human female reproductive tract tissue resource</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Archive and prospective tissue resource with &amp;amp; tissue bank approval;</gtr:description><gtr:id>0FACD32F-102A-4D60-9364-41D11D1431C4</gtr:id><gtr:impact>Multiple collaborations: local, some international and with industry

Tissue bank approval (since 2011) for this resource</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Human Female Reproductive Tract Tissue Resource</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Human endometrial samples categorised across the menstrual blood loss spectrum have provided resource for microarray studies and thus RNA dataset from women with heavy menstrual bleeding</gtr:description><gtr:id>AA3D2941-7602-4C31-AE80-BDC781AE137F</gtr:id><gtr:impact>Human endometrial samples categorised across the menstrual blood loss spectrum have provided RNA dataset from women with heavy bleeding -- this will permit detailed in silico analyses and pathway analyses that will direct future studies in women heavy menstrual bleeding</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Endometrial microarray data from women with heavy bleeding</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Female reproductive tract tissue archive (human endometrium and ovarian surface/ peritoneal surface epithelium) complemented with a computerised detailed dataset of consent records and patient characteristics for study participants since 2001.</gtr:description><gtr:id>0A4B945B-FF98-4AEC-9050-73FDC93A7F7D</gtr:id><gtr:impact>Invaluable resource to identify well-characterised cases for future re-use of stored tissue (with patient consent). Credible centralised source data for on-going, current and archived human female reproductive tract tissues.

We now have a &amp;quot;tissue bank approval&amp;quot; since 2011 for this resource</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Human female reproductive tract tissue resource</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Human endometrial samples categorised across the menstrual blood loss spectrum</gtr:description><gtr:id>09D4940B-2811-440F-9F69-7241D4D3D71E</gtr:id><gtr:impact>Provided opportunity for microarray analyses and thus generation of RNA data sets 
Tissue Resource for further collaborative studies -initially with other groups within local research environment</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Human endometrial samples categorised across the menstrual blood loss spectrum</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/15B91FDE-0F22-4994-B166-BD263A00DCD8"><gtr:id>15B91FDE-0F22-4994-B166-BD263A00DCD8</gtr:id><gtr:title>Inflammatory pathways in endometrial disorders.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/14661cfcf1a005e8090117ba86348d2c"><gtr:id>14661cfcf1a005e8090117ba86348d2c</gtr:id><gtr:otherNames>Maybin JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0303-7207</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BD57E2A1-A898-4A16-B35B-8528A2B3D822"><gtr:id>BD57E2A1-A898-4A16-B35B-8528A2B3D822</gtr:id><gtr:title>The importance of the macrophage within the human endometrium.</gtr:title><gtr:parentPublicationTitle>Journal of leukocyte biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/645c027f1823a0ad36d61f15f2d920c9"><gtr:id>645c027f1823a0ad36d61f15f2d920c9</gtr:id><gtr:otherNames>Thiruchelvam U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0741-5400</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5876D27F-7D57-4D64-9401-DB903807254B"><gtr:id>5876D27F-7D57-4D64-9401-DB903807254B</gtr:id><gtr:title>Placental growth factor: a promising diagnostic biomarker for tubal ectopic pregnancy.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/683eaf5521022c276588d0cfaba101ab"><gtr:id>683eaf5521022c276588d0cfaba101ab</gtr:id><gtr:otherNames>Horne AW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6980640F-10C7-4748-BD4E-36316822AA3B"><gtr:id>6980640F-10C7-4748-BD4E-36316822AA3B</gtr:id><gtr:title>Cortisol regulates the paracrine action of macrophages by inducing vasoactive gene expression in endometrial cells.</gtr:title><gtr:parentPublicationTitle>Journal of leukocyte biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/645c027f1823a0ad36d61f15f2d920c9"><gtr:id>645c027f1823a0ad36d61f15f2d920c9</gtr:id><gtr:otherNames>Thiruchelvam U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0741-5400</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/02532862-77C3-4D71-9DC1-97724B30D15A"><gtr:id>02532862-77C3-4D71-9DC1-97724B30D15A</gtr:id><gtr:title>Oestrogen and progesterone regulation of inflammatory processes in the human endometrium.</gtr:title><gtr:parentPublicationTitle>The Journal of steroid biochemistry and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0642d635cfac3d4704dc07a1afe39d9f"><gtr:id>0642d635cfac3d4704dc07a1afe39d9f</gtr:id><gtr:otherNames>King AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0960-0760</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6C415148-79ED-4A1C-A378-ED2D33EF8AB4"><gtr:id>6C415148-79ED-4A1C-A378-ED2D33EF8AB4</gtr:id><gtr:title>Novel roles for hypoxia and prostaglandin E2 in the regulation of IL-8 during endometrial repair.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/14661cfcf1a005e8090117ba86348d2c"><gtr:id>14661cfcf1a005e8090117ba86348d2c</gtr:id><gtr:otherNames>Maybin JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6E8AF306-C8C0-49CF-9244-6D2AD8E0C34E"><gtr:id>6E8AF306-C8C0-49CF-9244-6D2AD8E0C34E</gtr:id><gtr:title>Ectopic pregnancy as a model to identify endometrial genes and signaling pathways important in decidualization and regulated by local trophoblast.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ad3dae3f4c97b96194c70cc5b22847a0"><gtr:id>ad3dae3f4c97b96194c70cc5b22847a0</gtr:id><gtr:otherNames>Duncan WC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DA25BB0F-6695-4D57-B6D7-393EF01FD961"><gtr:id>DA25BB0F-6695-4D57-B6D7-393EF01FD961</gtr:id><gtr:title>Steroid regulation of menstrual bleeding and endometrial repair.</gtr:title><gtr:parentPublicationTitle>Reviews in endocrine &amp; metabolic disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/14661cfcf1a005e8090117ba86348d2c"><gtr:id>14661cfcf1a005e8090117ba86348d2c</gtr:id><gtr:otherNames>Maybin JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1389-9155</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/784B6EE9-CC4C-4745-AD3E-CCDDFDED6A0E"><gtr:id>784B6EE9-CC4C-4745-AD3E-CCDDFDED6A0E</gtr:id><gtr:title>The expression and regulation of adrenomedullin in the human endometrium: a candidate for endometrial repair.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/14661cfcf1a005e8090117ba86348d2c"><gtr:id>14661cfcf1a005e8090117ba86348d2c</gtr:id><gtr:otherNames>Maybin JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3A59B398-8106-44B4-9633-78B5C0248116"><gtr:id>3A59B398-8106-44B4-9633-78B5C0248116</gtr:id><gtr:title>Oestrogen and progesterone regulation of inflammatory processes in the human endometrium.</gtr:title><gtr:parentPublicationTitle>The Journal of steroid biochemistry and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0642d635cfac3d4704dc07a1afe39d9f"><gtr:id>0642d635cfac3d4704dc07a1afe39d9f</gtr:id><gtr:otherNames>King AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0960-0760</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/01E629CC-3AB6-4E05-94FF-F3DC6A63B961"><gtr:id>01E629CC-3AB6-4E05-94FF-F3DC6A63B961</gtr:id><gtr:title>Steroids regulate CXCL4 in the human endometrium during menstruation to enable efficient endometrial repair.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/14661cfcf1a005e8090117ba86348d2c"><gtr:id>14661cfcf1a005e8090117ba86348d2c</gtr:id><gtr:otherNames>Maybin JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A3DF4158-DD0B-4DCC-AEBD-525FF59A7E37"><gtr:id>A3DF4158-DD0B-4DCC-AEBD-525FF59A7E37</gtr:id><gtr:title>Molecular and cellular causes of abnormal uterine bleeding of endometrial origin.</gtr:title><gtr:parentPublicationTitle>Seminars in reproductive medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4ac0ac01fefa232a40f71da161f84a24"><gtr:id>4ac0ac01fefa232a40f71da161f84a24</gtr:id><gtr:otherNames>Critchley HO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1526-4564</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FBB2024D-C609-4142-A852-1B9778708586"><gtr:id>FBB2024D-C609-4142-A852-1B9778708586</gtr:id><gtr:title>Repair and regeneration of the human endometrium</gtr:title><gtr:parentPublicationTitle>Expert Review of Obstetrics &amp; Gynecology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e33fd2aa96b95b32af7f8ec22871ad04"><gtr:id>e33fd2aa96b95b32af7f8ec22871ad04</gtr:id><gtr:otherNames>Maybin J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E4BADDDC-FEF8-4727-975C-EF393B397459"><gtr:id>E4BADDDC-FEF8-4727-975C-EF393B397459</gtr:id><gtr:title>The presence and regulation of connective tissue growth factor in the human endometrium.</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/14661cfcf1a005e8090117ba86348d2c"><gtr:id>14661cfcf1a005e8090117ba86348d2c</gtr:id><gtr:otherNames>Maybin JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B0672A01-7334-4F6F-B0C2-65F62C4E4014"><gtr:id>B0672A01-7334-4F6F-B0C2-65F62C4E4014</gtr:id><gtr:title>Menstrual physiology: implications for endometrial pathology and beyond.</gtr:title><gtr:parentPublicationTitle>Human reproduction update</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/14661cfcf1a005e8090117ba86348d2c"><gtr:id>14661cfcf1a005e8090117ba86348d2c</gtr:id><gtr:otherNames>Maybin JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1355-4786</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E65A563D-C284-415A-9553-4E0A974DF67B"><gtr:id>E65A563D-C284-415A-9553-4E0A974DF67B</gtr:id><gtr:title>Inflammatory pathways in endometrial disorders.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/14661cfcf1a005e8090117ba86348d2c"><gtr:id>14661cfcf1a005e8090117ba86348d2c</gtr:id><gtr:otherNames>Maybin JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0303-7207</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/382CFC38-7470-49ED-8B23-994948769E72"><gtr:id>382CFC38-7470-49ED-8B23-994948769E72</gtr:id><gtr:title>Attenuated sex steroid receptor expression in fallopian tube of women with ectopic pregnancy.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/683eaf5521022c276588d0cfaba101ab"><gtr:id>683eaf5521022c276588d0cfaba101ab</gtr:id><gtr:otherNames>Horne AW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E5115972-70EE-4EE5-8B5B-21692A71C7E6"><gtr:id>E5115972-70EE-4EE5-8B5B-21692A71C7E6</gtr:id><gtr:title>Reconstruction of endometrium from human endometrial side population cell lines.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/790e743f6eb2dde704c44116c8ee9763"><gtr:id>790e743f6eb2dde704c44116c8ee9763</gtr:id><gtr:otherNames>Cervell? I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A350E47E-B57F-47BD-AE15-2ADA63A05870"><gtr:id>A350E47E-B57F-47BD-AE15-2ADA63A05870</gtr:id><gtr:title>Progesterone: a pivotal hormone at menstruation.</gtr:title><gtr:parentPublicationTitle>Annals of the New York Academy of Sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/14661cfcf1a005e8090117ba86348d2c"><gtr:id>14661cfcf1a005e8090117ba86348d2c</gtr:id><gtr:otherNames>Maybin JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0077-8923</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1911D497-E4B0-4B16-AEE9-B791F7897BD8"><gtr:id>1911D497-E4B0-4B16-AEE9-B791F7897BD8</gtr:id><gtr:title>Uterine NK cells regulate endometrial bleeding in women and are suppressed by the progesterone receptor modulator asoprisnil.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ce17895b9f3440de158d8f4358664af6"><gtr:id>ce17895b9f3440de158d8f4358664af6</gtr:id><gtr:otherNames>Wilkens J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/84DADF88-C262-4ECC-AF1B-2EF33C16F60F"><gtr:id>84DADF88-C262-4ECC-AF1B-2EF33C16F60F</gtr:id><gtr:title>Sex steroid hormones and reproductive disorders: impact on women's health.</gtr:title><gtr:parentPublicationTitle>Reproductive sciences (Thousand Oaks, Calif.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d8f3288d02fd2877231b3ac8c4ce2a5e"><gtr:id>d8f3288d02fd2877231b3ac8c4ce2a5e</gtr:id><gtr:otherNames>Fauser BC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1933-7191</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1BF06EEA-FB0E-4798-91D0-C0BAEF054995"><gtr:id>1BF06EEA-FB0E-4798-91D0-C0BAEF054995</gtr:id><gtr:title>The regulation of vascular endothelial growth factor by hypoxia and prostaglandin F2a during human endometrial repair.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/14661cfcf1a005e8090117ba86348d2c"><gtr:id>14661cfcf1a005e8090117ba86348d2c</gtr:id><gtr:otherNames>Maybin JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600048</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>FA7AA693-7EDD-4A7E-8CA3-6B5658FBF717</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Reproductive Health and Childbirth</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>